Interleukin-8 Overexpressing Collagen Microgel-Based Cellular Microtissue Accelerates the Healing of Diabetic Foot Ulcers
Chung H., Jang WY., Choi JK., Kim SH.
Animal Study on Diabetic Foot, Chronic Wound, published in Small (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Small (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41293988
- PMCID
- PMC12802542
- DOI
- 10.1002/smll.202511027
- Citations
- 1
Abstract (original English)
Diabetic foot ulcers (DFUs) represent a major clinical challenge due to impaired healing and limited therapeutic options. Although stem cell therapy offers regenerative potential, its efficacy is restricted by poor survival and engraftment at the injury site. To address this, collagen microgels (CMGs) are developed to assemble with cells to form CMG-based cellular microtissues (CCMs) with enhanced porosity, mass transfer, and viability. However, the diabetic microenvironment impairs healing by suppressing angiogenesis, keratinocyte migration, and fibroblast proliferation. Transcriptomic profiling identifies interleukin-8 (IL-8) as a key factor with multifaceted roles in promoting angiogenesis, migration, and proliferation. Compared with conventional aggregates, CCMs enhance adhesion, prevent anoikis, improve survival, and upregulate IL-8 via FGFR-integrin-ERK signaling. Functional studies using shRNA knockdown and adenoviral overexpression validate the therapeutic role of IL-8. In vitro co-culture with keratinocytes, fibroblasts, and endothelial cells shows that CCMs promoted migration, proliferation, and angiogenesis-effects diminished by IL-8 knockdown and amplified by overexpression. In a rat DFU model, CCMs accelerate wound closure by enhancing granulation tissue formation, collagen deposition, and expression of proliferative and angiogenic markers, all modulated by IL-8. T
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations